Studies from transgenic mouse models suggest that T cells are also crucial for disease resolution after infection with SARS-CoV-210, and SARS-CoV-2-specific CD4+ and CD8+ T cells have been associated with milder disease in human patients11, suggesting roles for coordinated adaptive immune responses in protective immunity against COVID-19. The gene discussed is CD8A; the disease is COVID-19.